APYX vs JNJ · rev $26.4M vs P/E 17, rev $49.37B
Apyx Medical Inc (APYX) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported APYX revenue for 2026-06-30 was $26.4M. Net income was -$5.4M. APYX currently screens at market cap $179.6M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
APYX currently screens at market cap $179.6M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the APYX and JNJ stock pages for the full models.
Not investment advice.